EUVIMEDEUVIMED entdecken
Crossref

Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin

Mohamed Abdellatif

International Journal of Clinical Pharmacy and Medicine · 10.07.2026 · 1 (2)

DOI: 10.68760/ijcpm.2026.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy and Medicine, online erschienen am 10.07.2026. Verfasst von Mohamed Abdellatif.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abdellatif, M. (2026). Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin. International Journal of Clinical Pharmacy and Medicine, 1(2). https://doi.org/10.68760/ijcpm.2026.06

Vancouver

Abdellatif M. Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin. International Journal of Clinical Pharmacy and Medicine. 2026;1(2). doi:10.68760/ijcpm.2026.06

BibTeX
@article{Abdellatif2026,
  author = {Abdellatif, Mohamed},
  title = {Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin},
  journal = {International Journal of Clinical Pharmacy and Medicine},
  year = {2026},
  volume = {1},
  number = {2},
  doi = {10.68760/ijcpm.2026.06}
}
Kostenlos starten →